ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 320,000
+8,500 (2.73%)
Aug 28, 2026, 3:30 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 22.28 trillion as of August 28, 2026. Its market cap has decreased by -1.43% in one year.
Market Cap
22.28T
Enterprise Value
21.94T
Revenue
203.76B
Ranking
n/a
PE Ratio
212.23
Stock Price
320,000.00
ChartMarket Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 22.28T, an increase of 18,475.24%. That is a compound annual growth rate of 56.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 22.28T | -7.31% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.71T |
| Celltrion | 45.77T |
| Samsung Epis Holdings | 9.59T |
| SK Biopharmaceuticals | 6.89T |
| HLB Co., Ltd. | 4.79T |
| Peptron | 4.39T |
| ABL Bio | 4.26T |
| LigaChem Biosciences | 3.67T |